Intensity Therapeutics, Inc To Start Trading Tomorrow

Intensity Therapeutics, Inc INTS IPO will take place October, 14 on the NASDAQ exchange under the ticker INTS.

The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on April 12, 2023.

See also: Benzinga IPO Calendar

About Intensity Therapeutics, Inc

Intensity Therapeutics, Inc is a clinical-stage biotechnology company whose treatment approach addresses both the regional and systemic nature of a patient's cancer

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.